Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

BUY
$0.22 - $0.66 $823 - $2,471
3,745 Added 26.72%
17,759 $6,000
Q3 2023

Nov 06, 2023

BUY
$0.2 - $1.78 $105 - $934
525 Added 3.89%
14,014 $3,000
Q2 2023

Jul 27, 2023

SELL
$1.02 - $1.89 $319 - $591
-313 Reduced 2.27%
13,489 $23,000
Q1 2023

May 02, 2023

SELL
$1.0 - $1.35 $1,341 - $1,810
-1,341 Reduced 8.86%
13,802 $15,000
Q4 2022

Feb 09, 2023

SELL
$0.87 - $1.33 $4 - $6
-5 Reduced 0.03%
15,143 $16,000
Q3 2022

Nov 02, 2022

SELL
$1.02 - $1.26 $3,973 - $4,908
-3,896 Reduced 20.46%
15,148 $18,000
Q2 2022

Aug 01, 2022

BUY
$0.91 - $2.01 $1,164 - $2,572
1,280 Added 7.21%
19,044 $19,000
Q1 2022

May 04, 2022

BUY
$1.22 - $2.03 $67 - $111
55 Added 0.31%
17,764 $28,000
Q4 2021

Feb 07, 2022

BUY
$1.27 - $2.23 $4,961 - $8,712
3,907 Added 28.31%
17,709 $24,000
Q3 2021

Nov 02, 2021

SELL
$2.12 - $2.76 $1,475 - $1,920
-696 Reduced 4.8%
13,802 $30,000
Q2 2021

Aug 03, 2021

SELL
$1.78 - $2.76 $776 - $1,203
-436 Reduced 2.92%
14,498 $36,000
Q1 2021

May 04, 2021

BUY
$0.94 - $3.31 $14,037 - $49,431
14,934 New
14,934 $34,000
Q2 2020

Aug 07, 2020

SELL
$0.56 - $1.41 $2,999 - $7,551
-5,356 Closed
0 $0
Q1 2020

May 04, 2020

BUY
$0.51 - $1.08 $1,372 - $2,907
2,692 Added 101.05%
5,356 $3,000
Q4 2019

Feb 04, 2020

BUY
$0.53 - $1.59 $283 - $850
535 Added 25.13%
2,664 $2,000
Q3 2019

Nov 12, 2019

BUY
$1.32 - $2.63 $2,810 - $5,599
2,129 New
2,129 $3,000

Others Institutions Holding OTLK

About Outlook Therapeutics, Inc.


  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $1.17B
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.